May 10, 2022

Cysmic GmbH is a member of the EVIDENCE consortium, which consists of 16 partners from academic research centers, diagnostic labs, blood supply centers, and small industries. The project is funded by the European Union’s Horizon 2020 grant and financed by the Marie Skłodowska-Curie Action Innovative Training Networks (ITN), which supports partnerships between industry and academia to develop and train early-stage researchers (ESR) worldwide. The global goal is to develop novel diagnostic and therapeutic tools for red blood cell (RBC) research.
This year, Cysmic attended the 2nd EVIDENCE Progress Meeting in Garmisch-Partenkirchen (Germany) from May 10th – 12th. The meeting provided an excellent opportunity to engage in fruitful discussions about current and future projects with red blood cell experts and industry professionals.

Read more about the EVIDENCE project at: